Detalhe da pesquisa
1.
Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria.
N Engl J Med
; 390(11): 994-1008, 2024 Mar 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38477987
2.
Tracing the evolutionary history of blood cells to the unicellular ancestor of animals.
Blood
; 140(24): 2611-2625, 2022 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36112959
3.
Population Pharmacokinetic Modeling of Posaconazole in Japanese Patients Receiving Fungal Prophylaxis.
Ther Drug Monit
; 2024 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38648638
4.
Pretreatment blast-to-lymphocyte ratio as a prognostic marker for CD19/CD3-bispecific T cell-engaging antibodies (blinatumomab) treatment against relapsed or refractory B-precursor acute lymphoblastic leukemia.
Cancer Immunol Immunother
; 72(11): 3861-3865, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37550429
5.
Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfan.
Ann Hematol
; 102(10): 2909-2922, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37052663
6.
Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan.
Int J Clin Oncol
; 28(6): 816-826, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37071252
7.
Development of a quantitative prediction model for peripheral blood stem cell collection yield in the plerixafor era.
Cytotherapy
; 24(1): 49-58, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34654641
8.
Oncolytic Virus Therapy with HSV-1 for Hematological Malignancies.
Mol Ther
; 29(2): 762-774, 2021 02 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33038943
9.
Next-generation sequencing in two cases of de novo acute basophilic leukaemia.
J Cell Mol Med
; 25(14): 7095-7099, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34132463
10.
The EZH2 inhibitor tazemetostat upregulates the expression of CCL17/TARC in B-cell lymphoma and enhances T-cell recruitment.
Cancer Sci
; 112(11): 4604-4616, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34449935
11.
Programmed cell death 1-expressing CD56-negative natural killer (NK) cell expansion is a hallmark of chronic NK cell activation during dasatinib treatment.
Cancer Sci
; 112(2): 523-536, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33064914
12.
[Clinical experience of leukapheresis for CD19 CAR-T cell therapy].
Rinsho Ketsueki
; 62(3): 163-169, 2021.
Artigo
Japonês
| MEDLINE | ID: mdl-33828008
13.
Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T-cell therapy.
Br J Haematol
; 200(1): e1-e3, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36220156
14.
Human CD1c⺠myeloid dendritic cells acquire a high level of retinoic acid-producing capacity in response to vitamin D3.
J Immunol
; 191(6): 3152-60, 2013 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23966631
15.
The tyrosine kinase inhibitor dasatinib suppresses cytokine production by plasmacytoid dendritic cells by targeting endosomal transport of CpG DNA.
Eur J Immunol
; 43(1): 93-103, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23112129
16.
Acute myeloid leukemia with a cryptic NUP98/PRRX2 rearrangement developing after low-dose methotrexate therapy for rheumatoid arthritis.
Ann Hematol
; 98(12): 2841-2843, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-31728617
17.
Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy.
Clin Exp Med
; 24(1): 105, 2024 May 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38771501
18.
Clinical Impact of Cytokine Release Syndrome on Prolonged Hematotoxicity after Chimeric Antigen Receptor T Cell Therapy: KyoTox A-Score, a Novel Prediction Model.
Transplant Cell Ther
; 30(4): 404-414, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38281589
19.
Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis.
Blood
; 117(2): 500-9, 2011 Jan 13.
Artigo
Inglês
| MEDLINE | ID: mdl-20956804
20.
Significance of Omitting Day 11 Mini-Dose Methotrexate for GVHD Prophylaxis After Unrelated Bone Marrow Transplantation.
Transplant Cell Ther
; 29(2): 119.e1-119.e7, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36372357